
Sign up to save your podcasts
Or


His plan to reclassify cannabis, so that it's no longer a Schedule I drug under the Controlled Substances Act, wouldn't make pot legal in the U.S., but it could help marijuana companies do more business. What does the research show about marijuana's harms, and does this fit Trump's call to "Make America Healthy Again"?
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Paul Gigot, The Wall Street Journal4.2
27362,736 ratings
His plan to reclassify cannabis, so that it's no longer a Schedule I drug under the Controlled Substances Act, wouldn't make pot legal in the U.S., but it could help marijuana companies do more business. What does the research show about marijuana's harms, and does this fit Trump's call to "Make America Healthy Again"?
Learn more about your ad choices. Visit megaphone.fm/adchoices

1,720 Listeners

4,423 Listeners

1,651 Listeners

1,539 Listeners

5,192 Listeners

4,907 Listeners

685 Listeners

1,451 Listeners

2,027 Listeners

2,830 Listeners

6,108 Listeners

712 Listeners

1,322 Listeners

8,459 Listeners

585 Listeners

151 Listeners

149 Listeners

1,105 Listeners

180 Listeners